Community/Retail

Elias Cachine, PharmD, discusses how pharmacists can prevent inappropriate antimicrobial use.

Elias Cachine, PharmD, discusses the factors that can potentially contribute to antimicrobial overuse in geriatric patients.

Elias Cachine, PharmD, discusses the potential complications that can arise as a result of antibiotic overuse in geriatric patients.

Demetra Antimisiaris, PharmD, CGP, FASCP, discusses the pharmacist's role in treating patients who are experiencing renal impairment.

Demetra Antimisiaris, PharmD, CGP, FASCP, discusses ways to avoid unintentional errors in renal dose adjustments.

Demetra Antimisiaris, PharmD, CGP, FASCP, discusses the best methods to use to estimate creatinine clearance levels.

Demetra Antimisiaris, PharmD, CGP, FASCP, discusses the potential complications that can arise from improper renal dosing.

Demetra Antimisiaris, PharmD, CGP, FASCP, discusses the factors that contribute to inappropriate renal dosing.

Alan G. Rosenbloom, president and CEO of Senior Care Pharmacy Coalition, talks about the Avalere Health Study: "Long-Term Care Pharmacy Sector Plays Key, Growing Role in US Seniors' Care as New Payment, Delivery Models Gain Prevalence in the industry."

Smart consumers can learn a lot from Black Friday.

The Institute for Safe Medication Practices (ISMP) is alerting pharmacists about the risks of mixing up idarucizumab (Praxbind) with idarubicin.

Any toy purchased at Meijer through November 30 will help the retailer grant a child's wish this holiday season.

Despite lingering controversy around marijuana, the use of medical cannabis for various conditions is accepted across a wide spectrum of states.

Beverly Schaefer, RPh, of Katterman's Sand Point Pharmacy in Seattle, Washington, talks about how to market traveling services at a pharmacy.

Donnie Calhoun, RPh, PD, National Community Pharmacists Association (NCPA) Foundation vice president, discusses how the Pharmacy Disaster Support Center can help pharmacists.

Ken Whittemore Jr, Surescript's senior vice president of professional and regulatory affairs, shares information on the current and future estimates of e-prescribing use.

Liz Tiefenthaler, president of Pharm Fresh Media, talks about what makes patients loyal to one pharmacy.

Treating low back pain with physical therapy soon after symptoms start does not make a clinically important difference when compared with starting therapy later.

James Schiffer, RPh, associate at Allegaert Berger & Vogel LLC, discusses some safeguards independent pharmacies can implement to avoid issues with controlled substance prescriptions.

Bryan Ziegler, PharmD, executive director of Kennedy Pharmacy Innovation Center, talks about important health care quality metrics for pharmacists and comments on how pharmacists can be active in driving value-based reimbursement.

As the health care landscape continues to change, pharmacy technicians have been increasingly holding leadership roles on their pharmacy teams.

Elias Cachine, PharmD, BCPS (AQ-10) explains what steps pharmacists should take when treating infections in geriatric patients.

Seven in 10 patients report some extent of nonadherence prior to a hospitalization caused by a cardiovascular event such as acute cardiac failure.

Viral shedding during influenza infections has 2 traits of interest to researchers: the quantity of virus shed and the pattern in which infected individuals shed virus over time.

Frances Sochovka was an extraordinary woman. She was dad's favorite aunt, and I was quite fond of her.

The US Senate has launched a bipartisan investigation into prescription drug pricing, targeting Valeant, Turing Pharma, Retrophin, and Rodelis in particular.

When you're out and about in your community, you will probably stumble upon a funny sign or billboard, and pharmacy signs are no exception.

AstraZeneca has entered into a definitive agreement to acquire ZS Pharma, a biopharmaceutical company based in San Mateo, California.

Students can use the Pharmacy Curriculum Outcomes Assessment to show potential employers that they are prepared to enter practice.

The FDA has given breakthrough therapy designation to Daiichi Sankyo and Plexxikon Inc's investigational oral CSF-1R inhibitor pexidartinib to treat tenosynovial giant cell tumor.